BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 25406082)

  • 1. Circulating microRNAs as a novel class of diagnostic biomarkers in gastrointestinal tumors detection: a meta-analysis based on 42 articles.
    Wang R; Wen H; Xu Y; Chen Q; Luo Y; Lin Y; Luo Y; Xu A
    PLoS One; 2014; 9(11):e113401. PubMed ID: 25406082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of circulating microRNAs as novel biomarkers in diagnosing colorectal cancer: a meta-analysis.
    Rokkas T; Kothonas F; Rokka A; Koukoulis G; Symvoulakis E
    Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):819-25. PubMed ID: 25856691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as noninvasive biomarkers in bladder cancer detection: a diagnostic meta-analysis based on qRT-PCR data.
    Xiao S; Wang J; Xiao N
    Int J Biol Markers; 2016 Jul; 31(3):e276-85. PubMed ID: 26954073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating microRNAs as novel biomarkers in the diagnosis of prostate cancer: a systematic review and meta-analysis.
    Yin C; Fang C; Weng H; Yuan C; Wang F
    Int Urol Nephrol; 2016 Jul; 48(7):1087-95. PubMed ID: 27068818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive power of circulating miRNAs in detecting colorectal cancer.
    Zeng W; Tu Y; Zhu Y; Wang Z; Li C; Lao L; Wu G
    Tumour Biol; 2015 Apr; 36(4):2559-67. PubMed ID: 25527153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical use of circulating microRNAs as non-invasive diagnostic biomarkers for lung cancers.
    Yang Y; Hu Z; Zhou Y; Zhao G; Lei Y; Li G; Chen S; Chen K; Shen Z; Chen X; Dai P; Huang Y
    Oncotarget; 2017 Oct; 8(52):90197-90214. PubMed ID: 29163821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating MicroRNA as Potential Source for Neurodegenerative Diseases Biomarkers.
    Zi Y; Yin Z; Xiao W; Liu X; Gao Z; Jiao L; Deng L
    Mol Neurobiol; 2015 Dec; 52(3):1494-1503. PubMed ID: 25367880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic value of circulating microRNAs as a biomarker for gastric cancer: A meta‑analysis.
    Wei H; Pu K; Liu XG; Li BX; Zhang HS; Wang H; Wang H; Sun WM; Wang YP
    Oncol Rep; 2019 Jan; 41(1):87-102. PubMed ID: 30320349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of circulating microRNAs as biomarkers for breast cancer: a meta-analysis study.
    Cui Z; Lin D; Song W; Chen M; Li D
    Tumour Biol; 2015 Feb; 36(2):829-39. PubMed ID: 25296735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs as novel biomarkers in the diagnosis of non-small cell lung cancer: a meta-analysis based on 20 studies.
    Chen L; Jin H
    Tumour Biol; 2014 Sep; 35(9):9119-29. PubMed ID: 25027397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
    Zhang L; Cao D; Tang L; Sun C; Hu Y
    Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico screening of circulating tumor DNA, circulating microRNAs, and long non-coding RNAs as diagnostic molecular biomarkers in ovarian cancer: A comprehensive meta-analysis.
    Zhang L; Hu C; Huang Z; Li Z; Zhang Q; He Y
    PLoS One; 2021; 16(4):e0250717. PubMed ID: 33901236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of circulating microRNAs for gastric cancer in Asian populations: a meta-analysis.
    Liu L; Wang S; Cao X; Liu J
    Tumour Biol; 2014 Dec; 35(12):11995-2004. PubMed ID: 25159040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update.
    Liu F; Tian T; Xia LL; Ding Y; Cormier RT; He Y
    Dis Esophagus; 2017 Feb; 30(2):1-9. PubMed ID: 27003597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating MiR-1290 as a potential diagnostic and disease monitoring biomarker of human gastrointestinal tumors.
    Xu L; Cai Y; Chen X; Zhu Y; Cai J
    BMC Cancer; 2021 Sep; 21(1):989. PubMed ID: 34479528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression and clinical significance of microRNAs in colorectal cancer detecting.
    Yang X; Zhong J; Ji Y; Li J; Jian Y; Zhang J; Yang W
    Tumour Biol; 2015 Apr; 36(4):2675-84. PubMed ID: 25480414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of circulating microRNAs in thyroid carcinoma: A systematic review and meta-analysis.
    Xu SL; Tian YY; Zhou Y; Liu LQ
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):489-498. PubMed ID: 32379941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Carter JV; Galbraith NJ; Yang D; Burton JF; Walker SP; Galandiuk S
    Br J Cancer; 2017 Mar; 116(6):762-774. PubMed ID: 28152545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs as a Novel Class of Diagnostic Biomarkers in Detection of Oral Carcinoma: a Meta-Analysis Study.
    Lin N; Lin Y; Fu X; Wu C; Xu J; Cui Z; Lin D
    Clin Lab; 2016; 62(3):451-61. PubMed ID: 27156336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microRNAs as biomarkers in hepatocellular carcinoma screening: a validation set from China.
    Jiang L; Cheng Q; Zhang BH; Zhang MZ
    Medicine (Baltimore); 2015 Mar; 94(10):e603. PubMed ID: 25761179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.